These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32633155)

  • 1. Design, synthesis, and
    Corrigan TS; Lotti Diaz LM; Border SE; Ratigan SC; Kasper KQ; Sojka D; Fajtova P; Caffrey CR; Salvesen GS; McElroy CA; Hadad CM; Doğan Ekici Ö
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1387-1402. PubMed ID: 32633155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8.
    James KE; Asgian JL; Li ZZ; Ekici OD; Rubin JR; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2004 Mar; 47(6):1553-74. PubMed ID: 14998341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases.
    Asgian JL; James KE; Li ZZ; Carter W; Barrett AJ; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2002 Nov; 45(23):4958-60. PubMed ID: 12408706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases.
    Ekici OD; Götz MG; James KE; Li ZZ; Rukamp BJ; Asgian JL; Caffrey CR; Hansell E; Dvorák J; McKerrow JH; Potempa J; Travis J; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2004 Apr; 47(8):1889-92. PubMed ID: 15055989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases).
    James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC
    Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.
    Ekici OD; Li ZZ; Campbell AJ; James KE; Asgian JL; Mikolajczyk J; Salvesen GS; Ganesan R; Jelakovic S; Grütter MG; Powers JC
    J Med Chem; 2006 Sep; 49(19):5728-49. PubMed ID: 16970398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of small molecule inhibitors and probes of human SUMO deconjugating proteases.
    Albrow VE; Ponder EL; Fasci D; Békés M; Deu E; Salvesen GS; Bogyo M
    Chem Biol; 2011 Jun; 18(6):722-32. PubMed ID: 21700208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of aza-peptide electrophile activity-based probes of caspases.
    Sexton KB; Kato D; Berger AB; Fonovic M; Verhelst SH; Bogyo M
    Cell Death Differ; 2007 Apr; 14(4):727-32. PubMed ID: 17170749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain.
    Lee J; Bogyo M
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1340-3. PubMed ID: 22243962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).
    Ovat A; Muindi F; Fagan C; Brouner M; Hansell E; Dvorák J; Sojka D; Kopácek P; McKerrow JH; Caffrey CR; Powers JC
    J Med Chem; 2009 Nov; 52(22):7192-210. PubMed ID: 19848405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
    Tsukamoto S; Yokosawa H
    Planta Med; 2010 Aug; 76(11):1064-74. PubMed ID: 20186654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
    Furet P; Imbach P; Fuerst P; Lang M; Noorani M; Zimmermann J; García-Echeverría C
    Bioorg Med Chem Lett; 2002 May; 12(10):1331-4. PubMed ID: 11992770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, SAR, and X-ray structure of novel potent DPPIV inhibitors: oxadiazolyl ketones.
    Koo KD; Kim MJ; Kim S; Kim KH; Hong SY; Hur GC; Yim HJ; Kim GT; Han HO; Kwon OH; Kwon TS; Koh JS; Lee CS
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4167-72. PubMed ID: 17544668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.
    Elofsson M; Splittgerber U; Myung J; Mohan R; Crews CM
    Chem Biol; 1999 Nov; 6(11):811-22. PubMed ID: 10574782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of new 3-alkoxy-7-amino-4-chloro-isocoumarin derivatives as new beta-amyloid peptide production inhibitors and their activities on various classes of protease.
    Bihel F; Quéléver G; Lelouard H; Petit A; Alvès da Costa C; Pourquié O; Checler F; Thellend A; Pierre P; Kraus JL
    Bioorg Med Chem; 2003 Jul; 11(14):3141-52. PubMed ID: 12818677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites.
    Kisselev AF; Garcia-Calvo M; Overkleeft HS; Peterson E; Pennington MW; Ploegh HL; Thornberry NA; Goldberg AL
    J Biol Chem; 2003 Sep; 278(38):35869-77. PubMed ID: 12815064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitor.
    Randolph JT; Zhang X; Huang PP; Klein LL; Kurtz KA; Konstantinidis AK; He W; Kati WM; Kempf DJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2745-50. PubMed ID: 18375121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR study of novel peptide aldehydes as inhibitors of 20S proteasome.
    Ma Y; Xu B; Fang Y; Yang Z; Cui J; Zhang L; Zhang L
    Molecules; 2011 Sep; 16(9):7551-64. PubMed ID: 21894088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K.
    Marquis RW; Ru Y; Yamashita DS; Oh HJ; Yen J; Thompson SK; Carr TJ; Levy MA; Tomaszek TA; Ijames CF; Smith WW; Zhao B; Janson CA; Abdel-Meguid SS; D'Alessio KJ; McQueney MS; Veber DF
    Bioorg Med Chem; 1999 Apr; 7(4):581-8. PubMed ID: 10353637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors.
    Akaji K; Konno H; Mitsui H; Teruya K; Shimamoto Y; Hattori Y; Ozaki T; Kusunoki M; Sanjoh A
    J Med Chem; 2011 Dec; 54(23):7962-73. PubMed ID: 22014094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.